{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:31:58Z","timestamp":1791322318566,"version":"4.3.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1038\/nrc2250","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T03:34:53Z","timestamp":1193196893000},"page":"880-887","source":"Crossref","is-referenced-by-count":350,"title":["Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy"],"prefix":"10.1038","volume":"7","author":[{"given":"Mario P.","family":"Colombo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Piconese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrc2250_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/213674a0","volume":"213","author":"RK Gershon","year":"1967","unstructured":"Gershon, R. K., Carter, R. L. & Kondo, K. On concomitant immunity in tumour-bearing hamsters. Nature 213, 674\u2013676 (1967).","journal-title":"Nature"},{"key":"BFnrc2250_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni1455","volume":"8","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. & Rudensky, A. Y. Foxp3 in control of the regulatory T cell lineage. Nature Immunol. 8, 457\u2013462 (2007).","journal-title":"Nature Immunol."},{"key":"BFnrc2250_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","volume":"13","author":"M Miyara","year":"2007","unstructured":"Miyara, M. & Sakaguchi, S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13, 108\u2013116 (2007).","journal-title":"Trends Mol. Med."},{"key":"BFnrc2250_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri1032","volume":"3","author":"JA Bluestone","year":"2003","unstructured":"Bluestone, J. A. & Abbas, A. K. Natural versus adaptive regulatory T cells. Nature Rev. Immunol. 3, 253\u2013257 (2003).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrc2250_CR5","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ni1444","volume":"8","author":"K Aschenbrenner","year":"2007","unstructured":"Aschenbrenner, K. et al. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nature Immunol. 8, 351\u2013358 (2007).","journal-title":"Nature Immunol."},{"key":"BFnrc2250_CR6","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","volume":"10","author":"T Takahashi","year":"1998","unstructured":"Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state. Int. Immunol. 10, 1969\u20131980 (1998).","journal-title":"Int. Immunol."},{"key":"BFnrc2250_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.192.2.303","volume":"192","author":"T Takahashi","year":"2000","unstructured":"Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303\u2013310 (2000).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni759","volume":"3","author":"J Shimizu","year":"2002","unstructured":"Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. & Sakaguchi, S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nature Immunol. 3, 135\u2013142 (2002).","journal-title":"Nature Immunol."},{"key":"BFnrc2250_CR9","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1182\/blood-2004-07-2959","volume":"105","author":"B Valzasina","year":"2005","unstructured":"Valzasina, B. et al. Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 105, 2845\u20132851 (2005).","journal-title":"Blood"},{"key":"BFnrc2250_CR10","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.4049\/jimmunol.172.6.3580","volume":"172","author":"I Takeda","year":"2004","unstructured":"Takeda, I. et al. Distinct roles for the OX40\u2013OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172, 3580\u20133589 (2004).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino, G. et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110, 1225\u20131232 (2007).","journal-title":"Blood"},{"key":"BFnrc2250_CR12","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257\u20131265 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.0105-2896.2005.00280.x","volume":"206","author":"AM Faria","year":"2005","unstructured":"Faria, A. M. & Weiner, H. L. Oral tolerance. Immunol. Rev. 206, 232\u2013259 (2005).","journal-title":"Immunol. Rev."},{"key":"BFnrc2250_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","volume":"212","author":"MG Roncarolo","year":"2006","unstructured":"Roncarolo, M. G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28\u201350 (2006).","journal-title":"Immunol. Rev."},{"key":"BFnrc2250_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1084\/jem.20050463","volume":"202","author":"F Ghiringhelli","year":"2005","unstructured":"Ghiringhelli, F. et al. Tumor cells convert immature myeloid dendritic cells into TGF\u03b2-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 202, 919\u2013929 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1182\/blood-2005-07-2737","volume":"107","author":"G Zhou","year":"2006","unstructured":"Zhou, G., Drake, C. G. & Levitsky, H. I. Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 107, 628\u2013636 (2006).","journal-title":"Blood"},{"key":"BFnrc2250_CR17","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1158\/0008-5472.CAN-05-4217","volume":"66","author":"B Valzasina","year":"2006","unstructured":"Valzasina, B., Piconese, S., Guiducci, C. & Colombo, M. P. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25\u2212 lymphocytes is thymus and proliferation independent. Cancer Res. 66, 4488\u20134495 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2250_CR18","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.4049\/jimmunol.178.4.2155","volume":"178","author":"G Zhou","year":"2007","unstructured":"Zhou, G. & Levitsky, H. I. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J. Immunol. 178, 2155\u20132162 (2007).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ni1318","volume":"7","author":"CS Hsieh","year":"2006","unstructured":"Hsieh, C. S., Zheng, Y., Liang, Y., Fontenot, J. D. & Rudensky, A. Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nature Immunol. 7, 401\u2013410 (2006).","journal-title":"Nature Immunol."},{"key":"BFnrc2250_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.immuni.2004.07.009","volume":"21","author":"CS Hsieh","year":"2004","unstructured":"Hsieh, C. S. et al. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21, 267\u2013277 (2004).","journal-title":"Immunity"},{"key":"BFnrc2250_CR21","doi-asserted-by":"publisher","first-page":"14571","DOI":"10.1073\/pnas.251547298","volume":"98","author":"H Nishikawa","year":"2001","unstructured":"Nishikawa, H. et al. Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity. Proc. Natl Acad. Sci. USA 98, 14571\u201314576 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc2250_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1471-4906(02)02281-0","volume":"23","author":"MB Lutz","year":"2002","unstructured":"Lutz, M. B. & Schuler, G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23, 445\u2013449 (2002).","journal-title":"Trends Immunol."},{"key":"BFnrc2250_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/eji.200425810","volume":"35","author":"C Guiducci","year":"2005","unstructured":"Guiducci, C., Valzasina, B., Dislich, H. & Colombo, M. P. CD40\/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell-produced IL-2. Eur. J. Immunol. 35, 557\u2013567 (2005).","journal-title":"Eur. J. Immunol."},{"key":"BFnrc2250_CR24","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","volume":"171","author":"Q Tang","year":"2003","unstructured":"Tang, Q. et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171, 3348\u20133352 (2003).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri1435","volume":"4","author":"TR Malek","year":"2004","unstructured":"Malek, T. R. & Bayer, A. L. Tolerance, not immunity, crucially depends on IL-2. Nature Rev. Immunol. 4, 665\u2013674 (2004).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrc2250_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ni1428","volume":"8","author":"JM Kim","year":"2007","unstructured":"Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunol. 8, 191\u2013197 (2007).","journal-title":"Nature Immunol."},{"key":"BFnrc2250_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1084\/jem.20041201","volume":"201","author":"S Liang","year":"2005","unstructured":"Liang, S. et al. Conversion of CD4+ CD25\u2212 cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201, 127\u2013137 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ni1265","volume":"6","author":"K Kretschmer","year":"2005","unstructured":"Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nature Immunol. 6, 1219\u20131227 (2005).","journal-title":"Nature Immunol."},{"key":"BFnrc2250_CR29","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1084\/jem.20070590","volume":"204","author":"JL Coombes","year":"2007","unstructured":"Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-\u03b2 and retinoic acid dependent mechanism. J. Exp. Med. 204, 1757\u20131764 (2007).","journal-title":"Exp. Med."},{"key":"BFnrc2250_CR30","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1084\/jem.20070602","volume":"204","author":"CM Sun","year":"2007","unstructured":"Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775\u20131785 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR31","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1084\/jem.20070719","volume":"204","author":"MJ Benson","year":"2007","unstructured":"Benson, M. J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R. J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204, 1765\u20131774 (2007).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR32","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4049\/jimmunol.179.2.967","volume":"179","author":"SF Yates","year":"2007","unstructured":"Yates, S. F. et al. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J. Immunol. 179, 967\u2013976 (2007).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR33","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1172\/JCI28941","volume":"116","author":"M Vukmanovic-Stejic","year":"2006","unstructured":"Vukmanovic-Stejic, M. et al. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 116, 2423\u20132433 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrc2250_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","volume":"22","author":"GP Dunn","year":"2004","unstructured":"Dunn, G. P., Old, L. J. & Schreiber, R. D. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329\u2013360 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrc2250_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nature Rev. Immunol. 6, 295\u2013307 (2006).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrc2250_CR36","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1084\/jem.159.5.1295","volume":"159","author":"RJ North","year":"1984","unstructured":"North, R. J. & Bursuker, I. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2\u2212 suppressor T cells down-regulate the generation of Ly-1\u22122+ effector T cells. J. Exp. Med. 159, 1295\u20131311 (1984).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR37","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1084\/jem.159.5.1312","volume":"159","author":"I Bursuker","year":"1984","unstructured":"Bursuker, I. & North, R. J. Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity. J. Exp. Med. 159, 1312\u20131321 (1984).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR38","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.4049\/jimmunol.175.8.5058","volume":"175","author":"T Hiura","year":"2005","unstructured":"Hiura, T. et al. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression. J. Immunol. 175, 5058\u20135066 (2005).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR39","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1158\/0008-5472.CAN-06-1432","volume":"66","author":"E Ambrosino","year":"2006","unstructured":"Ambrosino, E. et al. Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance. Cancer Res. 66, 7734\u20137740 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2250_CR40","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1038\/sj.bjc.6603824","volume":"96","author":"G Betts","year":"2007","unstructured":"Betts, G. et al. The impact of regulatory T cells on carcinogen-induced sarcogenesis. Br. J. Cancer 96, 1849\u20131854 (2007).","journal-title":"Br. J. Cancer"},{"key":"BFnrc2250_CR41","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1371\/journal.pone.0000129","volume":"1","author":"SL Clarke","year":"2006","unstructured":"Clarke, S. L. et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE 1, e129 (2006).","journal-title":"PLoS ONE"},{"key":"BFnrc2250_CR42","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942\u2013949 (2004).","journal-title":"Nature Med."},{"key":"BFnrc2250_CR43","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","volume":"169","author":"UK Liyanage","year":"2002","unstructured":"Liyanage, U. K. et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169, 2756\u20132761 (2002).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/cncr.11618","volume":"98","author":"T Sasada","year":"2003","unstructured":"Sasada, T., Kimura, M., Yoshida, Y., Kanai, M. & Takabayashi, A. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98, 1089\u20131099 (2003).","journal-title":"Cancer"},{"key":"BFnrc2250_CR45","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/sj.bjc.6602407","volume":"92","author":"C Schaefer","year":"2005","unstructured":"Schaefer, C. et al. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br. J. Cancer 92, 913\u2013920 (2005).","journal-title":"Br. J. Cancer"},{"key":"BFnrc2250_CR46","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1158\/0008-5472.CAN-06-0556","volume":"66","author":"JD Bui","year":"2006","unstructured":"Bui, J. D., Uppaluri, R., Hsieh, C. S. & Schreiber, R. D. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res. 66, 7301\u20137309 (2006).","journal-title":"Cancer Res."},{"key":"BFnrc2250_CR47","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.4049\/jimmunol.178.5.2883","volume":"178","author":"VC Liu","year":"2007","unstructured":"Liu, V. C. et al. Tumor evasion of the immune system by converting CD4+CD25\u2212 T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF\u2212\u03b2. J. Immunol. 178, 2883\u20132892 (2007).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR48","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","volume":"176","author":"F Fallarino","year":"2006","unstructured":"Fallarino, F. et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J. Immunol. 176, 6752\u20136761 (2006).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR49","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1182\/blood-2006-07-036863","volume":"109","author":"A Curti","year":"2007","unstructured":"Curti, A. et al. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25\u2212 into CD25+ T regulatory cells. Blood 109, 2871\u20132877 (2007).","journal-title":"Blood"},{"key":"BFnrc2250_CR50","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1182\/blood-2005-09-3671","volume":"107","author":"M Beyer","year":"2006","unstructured":"Beyer, M. et al. In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma. Blood 107, 3940\u20133949 (2006).","journal-title":"Blood"},{"key":"BFnrc2250_CR51","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.4049\/jimmunol.178.11.6901","volume":"178","author":"GL Stephens","year":"2007","unstructured":"Stephens, G. L., Andersson, J. & Shevach, E. M. Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J. Immunol. 178, 6901\u20136911 (2007).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR52","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1002\/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1","volume":"32","author":"D Golgher","year":"2002","unstructured":"Golgher, D., Jones, E., Powrie, F., Elliott, T. & Gallimore, A. Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. 32, 3267\u20133275 (2002).","journal-title":"Eur. J. Immunol."},{"key":"BFnrc2250_CR53","first-page":"1","volume":"2","author":"E Jones","year":"2002","unstructured":"Jones, E. et al. Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun. 2, 1 (2002).","journal-title":"Cancer Immun."},{"key":"BFnrc2250_CR54","first-page":"3128","volume":"59","author":"S Onizuka","year":"1999","unstructured":"Onizuka, S. et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor \u03b1) monoclonal antibody. Cancer Res. 59, 3128\u20133133 (1999).","journal-title":"Cancer Res."},{"key":"BFnrc2250_CR55","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","volume":"163","author":"J Shimizu","year":"1999","unstructured":"Shimizu, J., Yamazaki, S. & Sakaguchi, S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163, 5211\u20135218 (1999).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR56","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.4049\/jimmunol.176.3.1750","volume":"176","author":"A Comes","year":"2006","unstructured":"Comes, A. et al. CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine. J. Immunol. 176, 1750\u20131758 (2006).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR57","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/sj.onc.1210368","volume":"26","author":"TA Waldmann","year":"2007","unstructured":"Waldmann, T. A. Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia\/lymphoma. Oncogene 26, 3699\u20133703 (2007).","journal-title":"Oncogene"},{"key":"BFnrc2250_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trim.2007.03.001","volume":"18","author":"G Vlad","year":"2007","unstructured":"Vlad, G. et al. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl. Immunol. 18, 13\u201321 (2007).","journal-title":"Transpl. Immunol."},{"key":"BFnrc2250_CR59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1600-0897.2005.00330.x","volume":"54","author":"B Barnett","year":"2005","unstructured":"Barnett, B., Kryczek, I., Cheng, P., Zou, W. & Curiel, T. J. Regulatory T cells in ovarian cancer: biology and therapeutic potential. Am. J. Reprod. Immunol. 54, 369\u2013377 (2005).","journal-title":"Am. J. Reprod. Immunol."},{"key":"BFnrc2250_CR60","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1172\/JCI25947","volume":"115","author":"J Dannull","year":"2005","unstructured":"Dannull, J. et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115, 3623\u20133633 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrc2250_CR61","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.cji.0000175468.19742.10","volume":"28","author":"P Attia","year":"2005","unstructured":"Attia, P., Maker, A. V., Haworth, L. R., Rogers-Freezer, L. & Rosenberg, S. A. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J. Immunother. 28, 582\u2013592 (2005).","journal-title":"J. Immunother."},{"key":"BFnrc2250_CR62","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1002\/ijc.22617","volume":"120","author":"K Mahnke","year":"2007","unstructured":"Mahnke, K. et al. Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. Int. J. Cancer 120, 2723\u20132733 (2007).","journal-title":"Int. J. Cancer"},{"key":"BFnrc2250_CR63","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/bjo.2006.091165","volume":"90","author":"JB Ruddle","year":"2006","unstructured":"Ruddle, J. B., Harper, C. A., Honemann, D., Seymour, J. F. & Prince, H. M. A denileukin diftitox (Ontak) associated retinopathy? Br. J. Ophthalmol. 90, 1070\u20131071 (2006).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrc2250_CR64","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/01.cji.0000187959.45803.0c","volume":"29","author":"P Attia","year":"2006","unstructured":"Attia, P. et al. Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2. J. Immunother. 29, 208\u2013214 (2006).","journal-title":"J. Immunother."},{"key":"BFnrc2250_CR65","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1084\/jem.155.4.1063","volume":"155","author":"RJ North","year":"1982","unstructured":"North, R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J. Exp. Med. 155, 1063\u20131074 (1982).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR66","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00262-006-0225-8","volume":"56","author":"F Ghiringhelli","year":"2007","unstructured":"Ghiringhelli, F. et al. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol. Immunother. 56, 641\u2013648 (2007).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnrc2250_CR67","first-page":"8408","volume":"63","author":"IF Hermans","year":"2003","unstructured":"Hermans, I. F., Chong, T. W., Palmowski, M. J., Harris, A. L. & Cerundolo, V. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model. Cancer Res. 63, 8408\u20138413 (2003).","journal-title":"Cancer Res."},{"key":"BFnrc2250_CR68","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1182\/blood-2004-06-2410","volume":"105","author":"ME Lutsiak","year":"2005","unstructured":"Lutsiak, M. E. et al. Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 105, 2862\u20132868 (2005).","journal-title":"Blood"},{"key":"BFnrc2250_CR69","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1158\/0008-5472.CAN-06-2925","volume":"67","author":"DY Hou","year":"2007","unstructured":"Hou, D. Y. et al. Inhibition of indoleamine 2, 3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses. Cancer Res. 67, 792\u2013801 (2007).","journal-title":"Cancer Res."},{"key":"BFnrc2250_CR70","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nm1196","volume":"11","author":"AJ Muller","year":"2005","unstructured":"Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E. & Prendergast, G. C. Inhibition of indoleamine 2, 3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nature Med. 11, 312\u2013319 (2005).","journal-title":"Nature Med."},{"key":"BFnrc2250_CR71","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/nm1001-1118","volume":"7","author":"L Gorelik","year":"2001","unstructured":"Gorelik, L. & Flavell, R. A. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nature Med. 7, 1118\u20131122 (2001).","journal-title":"Nature Med."},{"key":"BFnrc2250_CR72","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","volume":"8","author":"DA Thomas","year":"2005","unstructured":"Thomas, D. A. & Massague, J. TGF-\u03b2 directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 8, 369\u2013380 (2005).","journal-title":"Cancer Cell"},{"key":"BFnrc2250_CR73","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1084\/jem.20041684","volume":"201","author":"P Yu","year":"2005","unstructured":"Yu, P. et al. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med. 201, 779\u2013791 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR74","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1084\/jem.20050940","volume":"202","author":"K Ko","year":"2005","unstructured":"Ko, K. et al. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells. J. Exp. Med. 202, 885\u2013891 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR75","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.4049\/jimmunol.176.11.6434","volume":"176","author":"T Ramirez-Montagut","year":"2006","unstructured":"Ramirez-Montagut, T. et al. Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance\/ignorance to melanoma differentiation antigens and enhances antitumor immunity. J. Immunol. 176, 6434\u20136442 (2006).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR76","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.4049\/jimmunol.177.7.4376","volume":"177","author":"S Read","year":"2006","unstructured":"Read, S. et al. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376\u20134383 (2006).","journal-title":"J. Immunol."},{"key":"BFnrc2250_CR77","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RP Sutmuller","year":"2001","unstructured":"Sutmuller, R. P. et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. 194, 823\u2013832 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnrc2250_CR78","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1172\/JCI27745","volume":"116","author":"SA Quezada","year":"2006","unstructured":"Quezada, S. A., Peggs, K. S., Curran, M. A. & Allison, J. P. CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J. Clin. Invest. 116, 1935\u20131945 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrc2250_CR79","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1113401","volume":"309","author":"G Peng","year":"2005","unstructured":"Peng, G. et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309, 1380\u20131384 (2005).","journal-title":"Science"},{"key":"BFnrc2250_CR80","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nri1371","volume":"4","author":"K Sugamura","year":"2004","unstructured":"Sugamura, K., Ishii, N. & Weinberg, A. D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nature Rev. Immunol. 4, 420\u2013431 (2004).","journal-title":"Nature Rev. Immunol."},{"key":"BFnrc2250_CR81","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta, A. et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl Acad. Sci. USA 103, 13132\u201313137 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrc2250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc2250","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrc2250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T09:45:42Z","timestamp":1684057542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc2250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["BFnrc2250"],"URL":"https:\/\/doi.org\/10.1038\/nrc2250","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}